جهاز ARS مقابل جهاز TPAK مقابل جهاز تخفيف الضغط بإبرة 14G من النوع العام: ما الذي يدفعه المشتري فعليًّا مقابل ذلك؟

Updated July 2026. Reviewed by the Rusun TacMed Technical Supply Desk.

A medical director and a procurement lead usually hit this comparison from opposite ends. The medical director’s side: the protocol was validated on a branded device, the kit insert names it, and changing hardware means change control, retraining, and sign-off. The procurement side: the branded line item carries a visible premium over a spec-matched generic, multiplied across thousands of kits on every reorder, and somebody has to say what that premium buys. Both are holding the same root question, and “which needle is better” is not it. For adult casualties, Tactical Combat Casualty Care (TCCC) guidance standardizes on a 14-gauge, 3.25-inch (8 cm) catheter-over-needle (CoTCCC Guidelines, Committee on TCCC, Joint Trauma System), and every device below is built around that same job. The question this guide answers is what a name adds on top of that settled spec — and when it is worth paying for.

ARS® (North American Rescue), TPAK® (Combat Medical), Turkel®, and Cook® are trademarks of their respective owners, and they earned their reputations. The question is not whether they work. It is which spec lines actually change the field outcome, which ones carry a brand premium, and when a certified generic 14G is the smarter buy for a five-figure restock or an OEM kit build. We manufacture the generic side of this comparison—so where a brand earns its premium, this guide says so plainly.

This is a sourcing guide, not a clinical how-to. For where the needle goes, see needle decompression sites and landmarks; for the needle-vs-chest-tube decision, see إزالة الضغط بالإبرة مقابل أنبوب الصدر. Site selection and clinical use belong to your medical director.

حقائق سريعة للمشترين

The short version: the brands win on named features and fielded pedigree; a certified generic wins on cost at volume with the same document set. That one sentence is most of the decision. The rest is knowing which of those two orders you are actually placing.

Quick Comparison: the NCD Devices Buyers Shortlist

The devices below share one clinical principle and one core spec (14G × 3.25 in). What differs is a patented feature here, packaging there, and price. Confirm the current configuration against each maker’s datasheet before you quote it in a tender: makers revise products.

The Spec-Parity Checklist: Where a Generic Must Match, and Where the Brand Premium Hides

When a decompression fails in the field, the failure clusters around bore, length, and catheter integrity — spec variables, not brand variables. That is why most “brand vs generic” NCD arguments miss the one useful question: on which lines must a generic be identical, and on which is the brand charging for a name? Run any two devices through these five lines.

1. Bore (gauge). The lumen has to vent air faster than it re-accumulates without the catheter collapsing under negative pressure. 14G is the adult standard; some programs specify 10G for maximum flow, since a 10-gauge lumen carries roughly 2.5× the airflow area of a 14-gauge, which is why ARS offers both (NAR). A generic must match the gauge your protocol validated. No substitution.
2. Usable length. The catheter has to reach the pleural space through a thicker-than-average chest wall, hence 3.25 in / 8 cm. This is not arbitrary: CT data behind the TCCC recommendation shows an 8 cm needle reaching the pleural space in ~99% of adults, while a 5 cm needle would be expected to fail in ~42.5% (JSOM 2018). Notice what that finding does: the military’s own trauma data locates the failure variable in a spec line (length), not in a brand name. That is a counterintuitive result for a market organized around brand loyalty, and it quietly reorders the sourcing decision: the spec line does the clinical work; the logo does not. Too short is the classic silent failure. Match the length exactly.
3. Catheter rigidity & material. After the needle withdraws, the catheter is the venting channel; if it kinks, buckles, or occludes, the pneumothorax re-accumulates. This is a real design variable: North American Rescue markets the Enhanced ARS specifically for a fenestrated catheter that reduces distal occlusion (NAR). It is also where cheap generics genuinely fail. Ask any supplier, brand or generic, for the catheter material and a kink/occlusion statement.
4. Certification & documentation. ISO 13485, CE (MDR), FDA-registered facility, per-batch COA, lot traceability. This is table stakes for a tender. It is also where a serious generic and a brand are on equal footing, not where you should pay a premium.
5. What the brand adds beyond 1–4. Sometimes real (a patented fenestrated catheter, a capless flash chamber, decades of fielded data, single-unit convenience). Sometimes just the logo. Name the specific thing you are buying; if you cannot, you are paying for the name.

النقطة الأساسية: Lines 1–3 must be identical to what your protocol validated: never trade them for price. Lines 4–5 are where the money decision actually lives. Documentation is parity, not premium; and a brand is only worth its markup when it adds a named feature on line 5.

(This checklist is the procurement companion to the clinical failure model on our product page. See the Catheter-Survival Gap on our chest decompression needle page for why bore, length and catheter integrity are the three variables NCD failures cluster around.)

When the Brand Is Worth It, and When a Certified Generic Wins

Neither answer is universal. Match the device to the order, not the reputation.

Decision Guide

In a 5,000-unit restock, the needle is a low line-item cost but a high rejection risk: one inconsistent batch can fail a whole tender. That is why the certified-generic decision is about documentation and batch consistency, not shaving cents.

The Brand-Premium Math: What You Actually Pay Across a Restock

For a single medic buying one needle, price is irrelevant. For a distributor building kits or a program restocking at scale, the brand premium multiplies across every unit and every reorder. The needle itself is a low per-unit cost; the four real B2B cost drivers are the same whether you buy branded or generic:

• Volume tier. Per-unit price falls in steps as quantity rises. The step boundaries, not the metal, decide your landed cost.
• Packaging. A branded single-unit clamshell costs more per piece than bulk-packed units assembled into your own kit. If you are building IFAKs, you are paying for packaging you will open and discard.
• Documentation. ISO 13485 / CE certificates, per-lot COA, Certificate of Origin, and correct customs classification. This is a fixed cost of doing the order properly, identical for brands and generics.
• Lead-time reliability. A missed delivery window on a tender is more expensive than any per-unit premium. Stated, held lead times have real value.

So the money question narrows to Spec-Parity line 5: Does the brand add something your program actually uses? Consider the arithmetic of a restock. Suppose a branded 14G unit carries even a modest $3–5 per-unit premium over a spec-matched generic (an illustrative figure; your actual delta comes from real quotes). Across a 5,000-unit restock that is $15,000–$25,000 per cycle, and it recurs on every reorder. If that premium buys a validated fenestrated catheter or a named protocol dependency, it is money well spent. If the honest answer is “it’s the same 14G × 8 cm catheter-over-needle we validated, just with a logo,” that delta is pure brand rent.

قاعدة اتخاذ القرار: Price the premium as unit delta × annual units × reorder frequency, then put it next to the specific line-5 feature it buys. If the feature column is blank, the premium is rent — source the certified generic.

For how per-unit generic NCD pricing is built in bulk, see the sourcing section of our إبرة تخفيف الضغط عن الصدر page. This guide covers the brand-vs-generic delta on top of that baseline.

The Export & Documentation Set: What Clears Customs and Passes a Tender

The reason a certified generic and a brand are on equal footing (Spec-Parity line 4) is that both must clear the same paperwork gates. For an international buyer, the document set is not administrative trivia: a missing or wrong document is what strands a container or bounces a tender submission. For a 14G × 8 cm NCD shipment, expect to assemble:

• Quality certificates. ISO 13485 and CE (MDR) certificate copies, plus the FDA facility registration if the destination asks for it. (We state facility registration, not 510(k) clearance; see What We Do Not Claim.)
• Per-lot Certificate of Analysis (COA). The batch-specific evidence that gauge, length, sterility, and catheter integrity meet spec. This is the single most important tender document, because it is what a buyer’s incoming inspection checks against.
• Certificate of origin, commercial invoice, and packing list. The standard export set for customs clearance.
• Correct customs classification. A catheter-over-needle NCD is typically classified under HS 9018.39 (catheters, cannulae, and the like); confirm the final code with your customs broker for the destination, as duty treatment varies by market.

Field note: The document set is where the cheapest bids quietly fall apart. A supplier who cannot produce a per-lot COA on request is a supplier whose batch consistency you cannot verify — and that is the risk that actually loses tenders, not the unit price.

Batch Consistency: the Real Tender-Rejection Risk

At a single-unit scale, one needle either works or it does not. At 5,000 units, the risk shifts from “does this needle work” to “does every needle in the lot meet spec.” Buyers meet this risk most often as the COA-less quote: a price comfortably under every other bid, from a supplier who cannot produce a per-lot Certificate of Analysis when asked. The number on that quote is real; the batch consistency behind it is unverifiable, which means what you are buying is not necessarily a worse needle but an unanswerable incoming inspection. A tender is won or lost on exactly that answer:

• Per-lot COA + traceable lot numbers, so a buyer can tie any unit back to its production batch.
• Incoming-inspection sampling (AQL). Agree on the acceptable quality level and sample plan before the order ships, so acceptance criteria are not disputed on arrival.
• A retained-sample and retest path if a lot is questioned, rather than a blanket rejection.

The arithmetic runs in reverse of the brand-premium math above. Suppose the COA-less quote saves $0.40 a unit: $2,000 across a 5,000-unit lot (illustrative, as before). Set that against what one rejected lot costs: the replacement order, the storage and demurrage while it is disputed, and, in a tender, the submission itself. The savings are rent in reverse, collected up front and repaid at incoming inspection. This is exactly where a serious generic supplier earns the order and the COA-less quote loses it — and it has nothing to do with the brand on the label.

Sourcing Outlook for 2026: What Moves, What Stays Fixed

Three forces shape an NCD sourcing decision this year, and they pull in opposite directions.

• The spec is frozen, and that is the buyer’s advantage. The 14G × 3.25 in (8 cm) standard is settled in TCCC guidance and has been stable for years (CoTCCC). Buyers often hesitate on a generic for fear it will be “outdated,” but the opposite is true: because the target configuration is not moving, a spec-matched device you validate today is a durable buy, not a bet on a moving target. The frozen spec is exactly what makes generic sourcing low-risk.
• Landed cost is where the volatility is. Duty treatment under HS 9018.39 and trade-policy shifts vary by destination and change faster than the device does: for many buyers they move total landed cost more than any unit price. Lock your customs classification and Incoterms early rather than assuming last year’s duty still applies.
• Lead times tighten on demand shocks. Medical-device demand spikes with conflict and disaster response, and tactical trauma supply is not immune. When it tightens, the buyers who held firm delivery windows in the contract, rather than the lowest quote, are the ones who restocked on time.

Outlook: The clinical spec is the stable part of this decision and the paperwork is the volatile part, so put your diligence into documentation, classification, and lead-time terms, not into worrying whether a 14G × 8 cm generic will be “current” next year. It will be.

What We Do Not Claim

Honesty here is a buying signal, not a weakness.

• ARS®, TPAK®, Turkel®, Cook® and SAM® SPEAR are trademarks of their respective owners. We are not those products, not a relabel, and not a counterfeit. Rusun TacMed supplies its own generic 14G × 8 cm catheter-over-needle NCD device sold under our own name.
• Comparisons here are nominative: we name other devices only to help a buyer choose, using each maker’s publicly published configuration, and we do not disparage them or copy their patented features (e.g. the fenestrated-catheter design is ARS’s).
• “The COA-less quote” names a pattern of quoting without batch documentation, not any company; certified branded and certified generic devices alike sit outside it.
• “FDA-registered facility” is not “FDA 510(k) cleared.” We state registration only.
• We claim no committee endorsement (e.g. CoTCCC). Our device is مصمم ليتوافق مع published needle-decompression guidance: alignment is not endorsement.
• All performance language is limited to confirmed specifications and cited public sources. We make no “guaranteed lifesaving” claims.

الأسئلة الشائعة

Is a generic decompression needle as good as an ARS needle?

For its field job, a generic that matches the validated spec (14G bore, 3.25 in / 8 cm usable length, a kink-resistant catheter) performs the same function as an ARS® 14G device, because both are built to the same TCCC-aligned configuration (CoTCCC). The premium buys named extras (e.g., the Enhanced ARS fenestrated catheter or the capless flash chamber) or reputation. Match the gauge, length and catheter integrity, confirm ISO 13485 / CE, and then the decision is about price, volume and paperwork, not efficacy.

What is the difference between ARS and TPAK decompression needles?

Both use a 14G × 3.25 in catheter-over-needle. ARS® (North American Rescue) also offers a 10-gauge option and an “Enhanced” version with a fenestrated catheter (NAR); TPAK® (Combat Medical) is known for flat, low-profile IFAK packaging and is described as better suited to a skilled operator (Reflex Medical). For a buyer the practical differences are bore choice, catheter design, and packaging, not a different clinical principle. Confirm current specs against each maker’s datasheet.

How much does an ARS-style needle decompression device cost in bulk?

The needle is a low per-unit item; in B2B the cost is driven by order volume, packaging (bulk vs. branded kit), documentation, and destination, not the metal, and branded devices add a name premium on top. As illustrative math, even a $3–5/unit brand premium across a 5,000-unit restock is $15,000–$25,000 per cycle, recurring each reorder. Send a target quantity, gauge (14G / 10G), and destination for FOB pricing on a spec-matched generic within 2 hours.

What export documents do you provide with a decompression needle order?

Expect ISO 13485 / CE certificate copies, a per-lot Certificate of Analysis, Certificate of Origin, commercial invoice and packing list, plus customs classification support (a catheter-over-needle NCD is typically HS 9018.39; confirm with your broker). The per-lot COA is the document your incoming inspection will check against, so it is the one to insist on before shipment.

How do I make sure a generic batch will pass our incoming inspection or tender?

Agree the terms before the order ships: a per-lot COA with traceable lot numbers, an incoming-inspection sampling plan (AQL) so acceptance criteria are fixed in advance, and a retained-sample re-test path if a lot is questioned. Batch consistency, not unit price, is what actually decides tender acceptance, and it is independent of the brand on the label.

Which gauge should I choose, 14G or 10G?

Match your validated protocol. 14G × 8 cm is the widely fielded adult standard; some programs specify a 10G heavy-bore for maximum flow (roughly 2.5× the airflow area), which is why ARS offers both (NAR). Do not switch gauge to save cost: pick the gauge your protocol validated, then source a device that matches it exactly.

What needle length is correct for a tension pneumothorax kit, and why 3.25 inches?

For adults, 14G × 3.25 in (8 cm). CT data behind the TCCC recommendation shows an 8 cm needle reaching the pleural space in about 99% of adults, while a 5 cm needle would be expected to fail in roughly 42.5% of cases (JSOM 2018). Short IV cannulas are not equivalent substitutes.

Are these needles CoTCCC-recommended?

We do not claim any committee endorsement. A device can be مصمم ليتوافق مع published TCCC-style guidance without being on a recommendation list: alignment is not endorsement. Ask any supplier (brand or generic) to show the endorsement in writing rather than infer it from marketing.

مقالات ذات صلة

• Chest Decompression Needle (NCD), the product page and per-unit sourcing home for the 14G × 8 cm device compared here
• إزالة الضغط بالإبرة مقابل أنبوب الصدر, when a needle is the right call in the field and when it is not
• مواقع ومعالم إزالة الضغط بالإبرة, where the 8 cm length actually has to reach
• ختم الصدر, the closest chest-trauma neighbour and the wound a decompression is often paired with
• ما هو TCCC؟, the protocol framework these devices are built to serve

Matching a spec against an ARS or TPAK quote?

شارك gauge (14G / 10G), the protocol wording your kit insert must support, الكمية المستهدفة, و destination, and we will return a spec-matched 14G × 8 cm NCD quote with packaging options and the full export document set against those requirements. Comparing line by line against a branded quote? Send it, and we will show you where a certified generic reaches parity and where it does not.

Request a Spec-Matched Quote →

— مكتب التوريدات الفنية في Rusun TacMed

نبذة عن هذا الدليل

Reviewed by the Rusun TacMed Technical Supply Desk. We manufacture the generic side of this comparison (a single 14G × 8 cm catheter-over-needle chest decompression needle with a protective case) and we do not make ARS, TPAK, or any branded device; that is exactly why this comparison can be honest about where a brand premium is and is not worth paying. Clinical and product statements are drawn from the public sources below and are provided for procurement context, not clinical guidance or endorsement: protocol and site-selection questions belong with your medical director. Trademarks are the property of their respective owners. Last updated: 2026-07-21.

المراجع والمصادر

1. إرشادات لجنة الرعاية التكتيكية للمصابين في ساحة القتال (CoTCCC) — Joint Trauma System, health. mil.
2. إدارة حالات الاسترواح الصدري التوتري المشتبه بها في إطار الرعاية التكتيكية للمصابين في ساحة القتال — Journal of Special Operations Medicine (2018), CoTCCC change package, via NAEMT.
3. إزالة الضغط بالإبرة في حالات الاسترواح الصدري الضاغط: توصيات إرشادات RCCS — Defense Health Board, health. mil.
4. الاسترواح الصدري المتوتر — StatPearls، NCBI Bookshelf، المكتبة الوطنية للطب.
5. ARS for Needle Decompression (14 gauge × 3.25 in) — North American Rescue.
6. Enhanced ARS Decompression Needle — North American Rescue (fenestrated catheter).
7. Needle Decompression Kit (TPAK) — Rescue Essentials.
8. Needle Decompression for Tension Pneumothorax: TPAK or PneumoDart — Reflex Medical.